Recurrent ovarian malignancy
The incidence of ovarian cancer ranks third among gynecological tumors, but its mortality rate ranks first. Since epithelial ovarian cancer is already in the advanced stage when diagnosed, standardized treatment, i.e. ideal tumor cell reduction surgery and combined chemotherapy with platinum or paclitaxel, has greatly improved the prognosis of some ovarian cancer patients.
-
Site of disease:
Ovaries -
Infectious :
Not contagious -
Frequent population:
Female population -
Related symptoms:
Stomach ache abdominal distension weight loss vaginal bleeding peritoneal effusion -
Concurrent disease:
Related Drugs
Amifostine for injection
Indication: 1. This product is a normal cell protective agent, mainly used for the adjuvant treatment of various cancers; 2. The use of this product before chemotherapy for patients with various cancers such as lung cancer, ovarian cancer, breast cancer, nasopharyngeal cancer, bone tumors, digestive tract tumors, and blood system tumors can significantly reduce the toxicity of chemotherapy drugs to the kidneys, bone marrow, heart, ears, and nervous systems without reducing the efficacy of chemotherapy drugs; 3. The use of this product before radiotherapy can significantly reduce the occurrence of dry mouth and mucositis.
Manufacturer:
Kaifeng MINGREN Pharmaceuticals Co., Ltd.
Related Ingredients